Andrew E. Budson, MD
Stephanie Faubion, MD, MBA, FACP, NCMP, IF
Lisa M. Ferreira, MD, FOMA
Joshua T. Goldman, MD, MBA
Aubrey J. Grant, MD, FACC
Jennifer Haley, MD
Pamela Kushner, MD, FAAFP
Gagan Mahajan, MD
Bruce D. Nicholson, MD
Vani Potluri, MD
Philip Schoenfeld, MD, MSEd, MSc
Charles Vega, MD, FAAFP
Shirah Vollmer, MD
Karol E. Watson, MD, PhD
Disclosures
The following financial relationships have been disclosed by faculty, and all have been mitigated by Pri-Med Institute. Relevant relationships will be disclosed at the start of each presentation.
Financial Disclosures
- Andrew E. Budson, MD
- Eli Lilly and AbbVie, Advisor; Vox Neuro and Bristol Meyers Squibb, Independent Contractor
- Stephanie Faubion, MD, MBA, FACP, NCMP, IF
- No relevant financial relationships disclosed.
- Lisa M. Ferreira, MD, FOMA
- Elil Lilly and Novo Nordisk Inc., Speaker
- Joshua T. Goldman, MD, MBA
- WHOOP,Inc., Researcher
- Aubrey J. Grant, MD, FACC
- No relevant financial relationships disclosed.
- Jennifer Haley, MD
- No relevant financial relationships disclosed.
- Pamela Kushner, MD, FAAFP
- GlaxoSmithKline, Novo Nordisk, AstraZeneca, Lilly, Abbott, Haleon, Bausch/SALIX, Corcept, Boehringer Ingelheim, Advisor; Novo Nordisk, Lilly, Boehringer Ingelheim, AstraZeneca, GlaxoSmithKline, Abbott, Phathom, Bausch/SALIX, Intuity, Pfizer, and Janssen., Speaker
- Gagan Mahajan, MD
- No relevant financial relationships disclosed.
- Bruce D. Nicholson, MD
- No relevant financial relationships disclosed.
- Vani Potluri, MD
- No relevant financial relationships disclosed
- Philip Schoenfeld, MD, MSEd, MSc
- Ironwood Pharmaceuticals, Ardelyx Pharmaceuticals, Phathom Pharmaceuticals, AbbVie Pharmaceuticals, Speaker; Phathom Pharmaceuticals, Ardelyx Pharmaceuticals, Consultant
- Charles Vega, MD, FAAFP
- Boehringer Ingelheim, and Exact Sciences, Consultant
- Shirah Vollmer, MD
- No relevant financial relationships disclosed
- Karol E. Watson, MD, PhD
- Amarin, Consultant; Amgen, Consultant; Boehringer Ingelheim, Consultant; Eli Lilly, Consultant; Novartis, Consultant
Other Disclosures
All other non-faculty contributors involved in the moderating, planning, development, editing and review of the content have disclosed no relevant financial relationships.